Core Points - The National Healthcare Security Administration has released the 11th batch of centralized drug procurement documents, emphasizing principles of "stabilizing clinical needs, ensuring quality, preventing collusion, and countering excessive competition" Group 1: Stabilizing Clinical Needs - The primary goal of the procurement is to ensure clinical medication needs, with a focus on optimizing procurement measures [2] - Medical institutions can report quantities based on either generic names or specific brands, with 77% of the reported quantities specified by brand [2] - The procurement volume is set at 60%-80% of the reported quantities, allowing institutions to choose the remaining portion independently [2] - New selection rules encourage major companies to participate by allowing them to match the prices of winning bids if their initial bids were not selected [2] - Special attention is given to ensuring the supply of pediatric medications, with adjusted pricing rules for small specifications [2] Group 2: Ensuring Quality - The procurement process incorporates higher quality control standards based on feedback from regulatory bodies [3] - Bidding companies must have at least two years of production experience for similar dosage forms and must pass GMP compliance checks [3] - The quality assessment now extends to the production line of the bidding drugs, requiring no GMP violations in the past two years [3] - Preference is given to companies with stable quality and clinical recognition when bids are equal [3] Group 3: Preventing Collusion - Measures to prevent collusion have been enhanced, including treating closely related companies as a single entity during bidding [4] - A "first to report leniency" mechanism is introduced to encourage reporting of collusion [4] - Stricter penalties are imposed on companies found to be colluding, including being placed on a "violation list" and facing maximum penalties under pricing and procurement credit evaluation systems [4] Group 4: Countering Excessive Competition - The procurement process promotes transparency and fair competition, with voluntary participation and self-quoted prices [5] - The rules for determining the highest effective bid have been optimized to prevent extreme price increases [5] - A new price control anchor is established, ensuring that if the lowest bid is below 50% of the average winning bid, the anchor will be set at 50% of the average [5] - Companies are required to commit to not quoting below their costs and must justify any low bids [6] - Selected companies are held responsible for supply guarantees and must fulfill orders promptly [6]
国家医保局：本次集采不再简单选用最低报价 要求企业不低于成本报价
智通财经网·2025-09-20 09:04